Dengue virus surveillance in Nepal yields the first on-site whole genome sequences of isolates from the 2022 outbreak
Male
Adult
Whole Genome Sequencing
Research
Capacity building
Dengue outbreak
Genome, Viral
QH426-470
Dengue Virus
Serogroup
Dengue virus
Disease Outbreaks
Dengue
Nepal
Whole genome sequencing
Genomic surveillance
Genetics
Humans
Female
TP248.13-248.65
Phylogeny
Biotechnology
DOI:
10.1186/s12864-024-10879-x
Publication Date:
2024-10-24T13:02:53Z
AUTHORS (18)
ABSTRACT
Abstract Background The 4 serotypes of dengue virus (DENV1-4) can each cause potentially deadly disease, and are spreading globally from tropical subtropical areas to more temperate ones. Nepal provides a microcosm this global phenomenon, having met these grim benchmarks. To better understand DENV transmission dynamics spread into new areas, we chose study in and, so doing, build the onsite infrastructure needed manage future, larger studies. Methods results During 2022 season, enrolled 384 patients presenting at hospital Kathmandu with dengue-like symptoms; 79% participants had active or recent infection (NS1 antigen IgM). identify circulating serotypes, screened serum 50 NS1 + by RT-PCR identified DENV1, 2, 3 – DENV1 codominant. We also performed whole-genome sequencing DENV, for first time Nepal, using our on-site capacity. Sequencing analysis demonstrated genomes clustered sequences reported India 2019, DENV2 genome sequence China 2018. Conclusion These findings highlight DENV’s geographic expansion neighboring countries, as likely origin cases demonstrate feasibility building capacity rapid genomic surveillance DENV. ongoing efforts promise protect populations beyond informing development deployment drugs vaccines real time.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (70)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....